Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Cash & Equivalents: 2018-2025

Historic Revenue - Interest and Investment Income for Zai Lab (ZLAB) over the last 1 years, with Jun 2020 value amounting to $548.2 million.

  • Zai Lab's Cash & Equivalents rose 16.41% to $717.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $717.2 million, marking a year-over-year increase of 16.41%. This contributed to the annual value of $449.7 million for FY2024, which is 43.09% down from last year.
  • Per Zai Lab's latest filing, its Cash & Equivalents stood at $717.2 million for Q3 2025, which was down 2.05% from $732.2 million recorded in Q2 2025.
  • Over the past 5 years, Zai Lab's Cash & Equivalents peaked at $1.8 billion during Q2 2021, and registered a low of $449.7 million during Q4 2024.
  • In the last 3 years, Zai Lab's Cash & Equivalents had a median value of $732.2 million in 2025 and averaged $715.6 million.
  • Data for Zai Lab's Revenue - Interest and Investment Income shows a peak YoY surged of 111.78% (in 2019) over the last 5 years.
  • Over the past 3 years, Zai Lab's Revenue - Interest and Investment Income (Quarterly) stood at $302.0 million in 2018, then climbed by 17.61% to $355.2 million in 2019, then climbed by 22.79% to $548.2 million in 2020.
  • Its last three reported values are $717.2 million in Q3 2025, $732.2 million for Q2 2025, and $757.3 million during Q1 2025.